Log in or Sign up for Free to view tailored content for your specialty!
Dermatitis News
Baricitinib improves outcomes in patients with atopic dermatitis
Patients with moderate-to-severe atopic dermatitis experienced improvements in both clinical and patient-reported outcomes after treatment with Olumiant plus topical corticosteroids when compared with topical corticosteroids alone, according to phase 2 study data presented at the European Academy of Dermatology and Venereology Annual Congress in Geneva.
FDA approves food label linking peanut introduction to reduced allergy risk
The FDA announced today that, for the first time, it has approved a petition for a qualified health claim linking early peanut introduction and the prevention of peanut allergy to be displayed on products containing ground peanuts.
Log in or Sign up for Free to view tailored content for your specialty!
Eucrisa demonstrated safety in atopic dermatitis
Encouraging safety outcomes were reported in a cohort of patients with atopic dermatitis who were treated with long-term Eucrisa.
Probiotics ineffective for preventing asthma, eczema in infants
The use of Lactobacillus rhamnosus GG, a probiotic, is unable to prevent asthma or eczema in children at 2 years of age when used in the first 6 months of life.
TopMD appoints dermatologist to medical advisory board
TopMD, the parent company of CLn Skin Care, announced it has appointed Kristin A. Romine, MD, to its medical advisory board.
Atopic dermatitis significantly impacts adults, AAD presenter reports
While atopic dermatitis is commonly diagnosed in infancy and early childhood, it can have a profound impact on adult patients, according to a presentation at the American Academy of Dermatology Summer Meeting in New York.
Topical corticosteroid phobia in atopic dermatitis tied to nonadherence
Patients with atopic dermatitis reported topical corticosteroid phobia, which appeared to play a role in nonadherence to treatment, according to recently published study results in JAMA Dermatology.
Phase 2a study shows efficacy for atopic dermatitis treatment
Glenmark Pharmaceuticals has announced positive data from its phase 2a study of GBR 830, an investigational anti-OX40 monoclonal antibody for treating atopic dermatitis.
Dermatologists can learn from veterinarians, AAD presenter reports
Dermatologists can learn from veterinarians as they research treatments for pets’ skin conditions, as such treatments may also benefit human patient conditions, including atopic dermatitis and rosacea, according to a presenter at the American Academy of Dermatology Summer Meeting in New York.
Top five dermatology stories in July include psoriasis studies, FDA approval
Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on Healio.com/Dermatology.
-
Headline News
VIDEO: If you want the health benefits of infrared light, ‘you’ve got to get outside’
September 23, 20248 min watch -
Headline News
FDA OKs Bimzelx for psoriatic arthritis, ankylosing spondylitis, non-radiographic axSpA
September 23, 20243 min read -
Headline News
Early childhood exposure to more green spaces linked to improved lung function
September 24, 20242 min read
-
Headline News
VIDEO: If you want the health benefits of infrared light, ‘you’ve got to get outside’
September 23, 20248 min watch -
Headline News
FDA OKs Bimzelx for psoriatic arthritis, ankylosing spondylitis, non-radiographic axSpA
September 23, 20243 min read -
Headline News
Early childhood exposure to more green spaces linked to improved lung function
September 24, 20242 min read